Compare Global X Defense Tech ETF (SHLD) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X Defense Tech ETF vs Tenet Healthcare Corporation — how do they compare? Global X Defense Tech ETF trades at $59.92 (market cap $6.38B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Tenet Healthcare Corporation is far larger — about 3.3× Global X Defense Tech ETF's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Global X Defense Tech ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Global X Defense Tech ETF for 44 Days and Tenet Healthcare Corporation for 15 Days on average.
| SHLD | THC | |
|---|---|---|
Market Cap | $6.38B | $20.92B |
Volume | 1,280,546 | 455,764 |
Sector | Sector/Thematic | Health |
52-Week High | $78.02 | $280.77 |
52-Week Low | $58.20 | $161.37 |
Typical Hold Time | 44 Days | 15 Days |
Enterprise Value | — | $32.00B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SHLD (Global X Defense Tech ETF) trades at $58.74, down 2.2% on the day amid bearish technical signals. The ETF faces selling pressure with all 13 moving averages signaling bearish momentum, though oversold RSI readings at 10.99 (6-day) and 15.12 (12-day) suggest potential for near-term bounce. Recent institutional filings show increased buying interest from firms like Focus Financial Network (+55.4% stake) and Balefire LLC ($1.12M new position) in Q2 2026, indicating professional confidence in defense tech exposure.
The defense technology sector benefits from geopolitical tensions and rising global military budgets, with EU allies planning significant rearmament spending. However, the ETF's concentrated focus on emerging tech carries execution risks versus broader aerospace peers. Current technical weakness contrasts with fundamental tailwinds, creating a divergence that may resolve with either sector momentum recovery or continued ETF-specific pressure.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Global X Defense Tech ETF
SHLD tracks the Global X Defense Tech Index, targeting companies that lead the technological transformation of the defense sector. It focuses on pure-play innovators in cybersecurity, artificial intelligence, robotics, and advanced military systems, excluding traditional commercial aerospace to maintain a high level of thematic purity.
Read more on SHLD →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
